CLINICAL_TRIALS
trial_result
· 2012-02-01
Clinical Trial Update: Remicade Safety Line (Study P03236)(COMPLETED)
Summary
The Remicade Safety Line study P03236 in rheumatoid arthritis has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Arthritis, Rheumatoid | Status: COMPLETED | Results posted: 2012-02-01